A life-threatening abscess in a patient treated with a tumour necrosis factor-alpha antagonist: a case report.

about

A life-threatening abscess in a patient treated with a tumour necrosis factor-alpha antagonist: a case report.

Item

http://www.wikidata.org/entity/Q43282843

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

A life-threatening abscess in ...... pha antagonist: a case report.

@en

A life-threatening abscess in ...... pha antagonist: a case report.

@nl

type

Item

label

A life-threatening abscess in ...... pha antagonist: a case report.

@en

A life-threatening abscess in ...... pha antagonist: a case report.

@nl

prefLabel

A life-threatening abscess in ...... pha antagonist: a case report.

@en

A life-threatening abscess in ...... pha antagonist: a case report.

@nl

P1476

A life-threatening abscess in ...... pha antagonist: a case report.

@en

P2093

Dieter Cadosch

http://www.w3.org/2001/XMLSchema#string

Lisa Neukom

http://www.w3.org/2001/XMLSchema#string

Oliver P Gautschi

http://www.w3.org/2001/XMLSchema#string

Rene Zellweger

http://www.w3.org/2001/XMLSchema#string

P2860

Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

Classification of the spondyloarthropathies.

Infections associated with tumor necrosis factor-alpha antagonists.

Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.

Infections in patients with rheumatoid arthritis treated with biologic agents.

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

P304

227-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/230949900901700223

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19721159

http://www.w3.org/2001/XMLSchema#string

P921

TNF